STOCK COMMENTS / EPS CHANGESBiogen Idec ( BIIB) target raised at Oppenheimer to $145. Analyst day highlights pipeline strength. Outperform rating. CNO Financial ( CNO) added to Conviction Buy List at Goldman. Company can grow faster than its life insurance peers. Buy rating and $9 price target. Forest Laboratories ( FRX) estimates cut at Morgan Stanley through 2014, Morgan Stanley said. Company lowered its guidance. $35 price target. Great Plains Energy ( GXP) added to Top Picks Live! at Citigroup. $23 price target. Valuation gap should narrow as rates come closer to fruition and regulatory concerns diminish. Hershey ( HSY) added to Conviction Buy List at Goldman. Company can deliver above-average sales and earnings growth. $76 price target. JPMorgan Chase ( JPM) target lowered at Oppenheimer to $56. Contraction of market multiple. Outperform rating. Mastercard ( MA) numbers lowered at Jefferies. Shares of MA now seen reaching $507, Jefferies said. Estimates also lowered on FX and macro risks. Buy rating. Altria ( MO) target raised at Morgan Stanley to $30, according to Morgan Stanley. There's room for industry price increases in the U.S. Scotts Miracle-Gro ( SMG) numbers cut at BofA/Merrill. Shares of SMG now seen reaching $39, according to Bank of America/Merrill Lynch. Estimates also reduced, given the company's new guidance. Underperform rating. AT&T ( T) target raised at Jefferies to $36, Jefferies said. Divestiture of Advertising Solutions should help value gap close. Hold rating. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.